A group of angels turns up their nose at a company making a useful, well-targeted and well-validated computer peripheral product. The smart entrepreneur behind the company asks a pretty fundamental question in response: “Why do angel investors often turn up their noses at real, down-to-earth physical product companies and instead chase ethereal web and process flow services businesses?”
- Clinical Trial Confirms GammaTile Superior Tumor Control
 - 2025 Brutal Biotech Investment Climate
 - Delta Development Team – Introducing BloodCOMM Premium
 - Special Operations Forces Blood Cooler from Delta Development
 - UACI startup alumni Reglagene making impressive strides in brain cancer treatment
 - Reglagene RGN6024 Cover Story August 2025 Molecular Cancer Therapeutics
 - Calls for More Angel Investing
 - Takes a Licking and Keeps on Ticking
 - Ventura County firefighters make history with in-the-field blood transfusions
 - FireRescue1’s “3 Things We’re Watching at FDIC 2025